Trials / Completed
CompletedNCT01041807
Cozaar XQ Re-examination Study (MK-0954-349)
Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of COZAAR XQ in Usual Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 669 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This survey is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Law and its Enforcement Regulation; its aim is to reconfirm the clinical usefulness of COZAAR XQ through collecting the safety and efficacy information according to the Re-examination Regulation for New Drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amlodipine/losartan | amlodipine/losartan (COZAAR XQ) prescribed according to the current local label |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2010-01-01
- Last updated
- 2022-02-15
Source: ClinicalTrials.gov record NCT01041807. Inclusion in this directory is not an endorsement.